NCT00995254
- Conditions
- Behavior, Health Behavior, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- Community Health Centers Shanghai, Shanghai Municipality, China
Clinical trial condition
Smoking Cessation
Explore clinical trials studying Smoking Cessation. Study availability and eligibility vary by location and protocol.
912 public trials
85 recruiting studies
Smoking Cessation trial results
NCT00563511
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- HKFPA Hong Kong, China
- Kwong Wah Hospital Hong Kong, China
- The University of Hong Kong Hong Kong, China
- WHO Hong Kong, China
NCT00563199
- Conditions
- Behavior, Health Behavior, Smoking, +1 more
- Locations
-
- Caritas Medical Centre Hong Kong, China
- Pamela Youde Nethersole Eastern Hospital Hong Kong, China
- Princess Margaret Hospital Hong Kong, China
- Queen Elizabeth Hospital Hong Kong, China
NCT01369693
- Conditions
- Behavior, Harm Reduction, Health Behavior, +3 more
- Locations
-
- CROel AB Helsingborg, Sweden
NCT00366977
- Conditions
- Behavior, Cost-effectiveness, Health Behavior, +3 more
- Locations
-
- Kaiser Permanente Center for Health Research Portland, Oregon, United States
- Oregon Health Division/Center for Disease Prevention Epidemiology Portland, Oregon, United States
- Free and Clear, Inc. Seattle, Washington, United States
NCT00644969
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Aurora, Colorado, United States
- Pfizer Investigational Site Farmington, Connecticut, United States
- Pfizer Investigational Site New Haven, Connecticut, United States
- Pfizer Investigational Site Worcester, Massachusetts, United States
NCT00794365
- Conditions
- Behavior, Health Behavior, Smoking, +1 more
- Locations
-
Not specified
NCT00358228
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Sanofi-Aventis Administrative Office Malvern, Pennsylvania, United States
NCT00464165
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Sanofi-Aventis Administrative Office Diegem, Belgium
- Sanofi-Aventis Administrative Office Hørsholm, Denmark
- Sanofi-Aventis Administrative Office Paris, France
- Sanofi-Aventis Administrative Office Barcelona, Spain
Completed
Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation
NCT00464256
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States